District Court Gives Final Approval For Shamir – Essilor Transaction
KIBBUTZ SHAMIR, Israel, June 14, 2011 /PRNewswire/ — Shamir Optical Industry Ltd. (Nasdaq: SHMR) (“Shamir”), a leading provider of innovative products and technology to the ophthalmic lens market, today announced that on June 13, 2011, the District Court of Nazareth gave its final approval for Essilor Corporation to complete its acquisition of 50% of Shamir, following the approval of the transaction by Shamir’s shareholders. The closing of the transaction remains subject to the satisfaction of the remaining conditions specified by the transaction agreements.
Shamir is a leading provider of innovative products and technology to the spectacle lens market. Utilizing its proprietary technology, the company develops, designs, manufactures, and markets progressive lenses to sell to the ophthalmic market. In addition, Shamir utilizes its technology to provide design services to optical lens manufacturers under service and royalty agreements. Progressive lenses are used to treat presbyopia, a vision condition where the eye loses its ability to focus on close objects. Progressive lenses combine several optical strengths into a single lens to provide a gradual and seamless transition from near to intermediate, to distant vision. Shamir differentiates its products from its competitors’ primarily through lens design. Shamir’s leading lenses are marketed under a variety of trade names, including Shamir Creation(TM), Shamir Piccolo(TM), Shamir Office(TM), Shamir Autograph(TM), and Shamir Attitude(TM). Shamir believes that it has one of the world’s preeminent research and development teams for progressive lenses, molds, and complementary technologies and tools. Shamir developed software dedicated to the design of progressive lenses. This software is based on Shamir’s proprietary mathematical algorithms that optimize designs of progressive lenses for a variety of activities and environments. Shamir also has created software tools specifically designed for research and development and production requirements, including Eye Point Technology software, which simulates human vision.
Safe Harbor Statement
Statements concerning the contemplated merger and related transactions, Shamir’s business outlook or future economic performance; product introductions and plans and objectives related thereto; and assumptions made or expectations as to any future events, conditions, performance or other matters, are “forward-looking statements” as that term is defined under U.S. federal securities laws. Forward-looking statements are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from those stated in such statements. These risks, uncertainties and factors include, but are not limited to: the inability to close the transactions referred to herein, the conflicts in the region; the effects of competition in our industry, and changes in our relationships with optical laboratories, distributors, research and development partners and other third parties; the effects of the international expansion of our operations and our ability to manage our growth, including our ability to manage potential future acquisitions; the effect of global economic conditions in general and conditions in Shamir’s industry and target markets in particular; shifts in supply and demand; market acceptance of new products and continuing products’ demand; the impact of competitive products and pricing on Shamir’s and its customers’ products and markets; timely product and technology development/upgrades and the ability to manage changes in market conditions as needed; interest rate fluctuations; and other factors detailed in Shamir’s filings with the Securities and Exchange Commission. Shamir assumes no obligation to update the information in this release.
Investor Relations Contacts: Roni Gavrielov Jeffrey Goldberger KM / KCSA Investor Relations KCSA Strategic Communications +972-3-516-7620 212-896-1249 firstname.lastname@example.org email@example.com